NDC 64896-662 – Rytary
Levodopa 145 mg/1; Carbidopa Hydrate 36.25 mg/1 · Capsule, Extended Release · Oral
Product NDC64896-662
Product details
- Brand name
- Rytary
- Generic name
- Carbidopa and Levodopa
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA203312
- Marketed since
- January 12, 2015
- Listing expires
- December 31, 2027
- Pharmacologic class
- Aromatic Amino Acid
Active ingredients
- Levodopa 145 mg/1
- Carbidopa Hydrate 36.25 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 64896-662-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-662-01) | Jan 12, 2015 |
| 64896-662-09 | 25 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-662-09) | Jan 12, 2015 |
| 64896-662-43 | 240 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-662-43) | Jan 12, 2015 |
| 64896-662-99 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-662-99) | Jan 12, 2015 |
Other Rytary products
- 64896-661 Levodopa 95 mg/1; Carbidopa Hydrate 23.75 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals LLC
- 64896-663 Levodopa 195 mg/1; Carbidopa Hydrate 48.75 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals LLC
- 64896-664 Levodopa 245 mg/1; Carbidopa Hydrate 61.25 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals LLC